Hutchens & Kramer Investment Management Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
RT
PAS
Hutchens & Kramer Investment Management Group's ELV Position: Q3 2026 in Review
Hutchens & Kramer Investment Management Group increased its Elevance Health (ELV) stake by 0.99% in Q3 2026, buying an estimated $3.19K and bringing the position to 814 shares worth $316K. The position accounts for 0.09% of the portfolio, ranked #113.
Hutchens & Kramer Investment Management Group first reported a position in ELV in Q4 2022 and has held it in 13 quarters since. The position peaked at $661K in Q2 2025. 204 funds tracked by Wall St. Rank hold ELV as of Q3 2026.
- Hutchens & Kramer Investment Management Group held 814 shares of Elevance Health worth $316K as of Q3 2026.
- Hutchens & Kramer Investment Management Group bought 8 Elevance Health shares in Q3 2026, an estimated $3.19K.
- Elevance Health made up 0.09% of Hutchens & Kramer Investment Management Group's portfolio in Q3 2026, its #113 holding.
- Hutchens & Kramer Investment Management Group first reported a position in Elevance Health in Q4 2022 and has held it in 13 quarters since.
- Hutchens & Kramer Investment Management Group's Elevance Health position peaked at $661K in Q2 2025.
- 204 funds tracked by Wall St. Rank held Elevance Health as of Q3 2026.
Based on Hutchens & Kramer Investment Management Group's 13F filing for Q3 2026, filed 16 Oct 2026.